Eyeonics Inc., an Aliso Viejo-based medical device maker, has filed plans to raise up to $86.3 million in an initial public offering.
Eyeonics makes eye replacement lenses for cataract patients. Its lead product is the Crystalens, an implantable lens designed to offer users “natural vision” after cataract surgery.
The company received regulatory clearance for Crystalens in 2003 and began selling it in 2004. In its filing, Eyeonics said it’s sold about 75,000 Crystalenses to some 1,000 doctors.
Venture investors in Eyeonics include Versant Ventures, which has offices in Newport Beach and Menlo Park.
William Link, a Versant managing director, was Eyeonics’ first investor and worked with Chief Executive J. Andy Corley at Allergan Inc. of Irvine. Link serves as an Eyeonics director.
Through the first six months of this year, Eyeonics lost $3.5 million on revenue of $13.6 million. Last year, the company lost $4.4 million on revenue of $8.4 million.
Eyeonics, which was started nine years ago, had 105 workers as of the end of June, most in sales and marketing.
Eyeonics has applied to have its shares trade on the Nasdaq Global Markets exchange under the ticker “EYON.” The company hasn’t set a date for its offering.
